Registration of APIs CMC information required for an IND
IND and NDA support Drug master files (DMF) filing
Synonyms/Alias | 111790-37-5;N-(2-Aminoethyl)biotinamide;Biotin-EDA;N-(2-Aminoethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide;Biotinylamidoethylacetamide;5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-N-(2-aminoethyl)pentanamide;BAEA;1H-Thieno(3,4-d)imidazole-4-pentanamide, N-(2-aminoethyl)hexahydro-3-oxo-, (3aS,4S,6aR)-;biotinylethylenediamine;C12H22N4O2S;2-[(+)-Biotinamido]ethylamine;BNCJEZWKLUBUBB-QXEWZRGKSA-N;5-[(3AS,4S,6AR)-2-OXO-HEXAHYDROTHIENO[3,4-D]IMIDAZOL-4-YL]-N-(2-AMINOETHYL)PENTANAMIDE;MFCD09839905;(+)-Biotinyl ethylamine;N-(2-aminoethyl) biotinamide;SCHEMBL3256514;DTXSID90920566;AKOS024464458;AS-47006;BP-21740;HY-130893;A3131;CS-0116326;F11303;N-(2-Aminoethyl)-5-(2-hydroxy-3a,4,6,6a-tetrahydro-1H-thieno[3,4-d]imidazol-6-yl)pentanimidic acid; |
M.F/Formula | C12H22N4O2S |
M.W/Mr. | 286.4 |
InChI | InChI=1S/C12H22N4O2S/c13-5-6-14-10(17)4-2-1-3-9-11-8(7-19-9)15-12(18)16-11/h8-9,11H,1-7,13H2,(H,14,17)(H2,15,16,18)/t8-,9-,11-/m0/s1 |
InChI Key | BNCJEZWKLUBUBB-QXEWZRGKSA-N |
3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
5. Emu oil in combination with other active ingredients for treating skin imperfections
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us. We will endeavor to provide highly satisfying products and services.